Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
CALL
ENI
E
$76.1B
| $4.39M | ﹤0.01% |
213,300
-50,800
| -19% | -$919K |
|
3577
CALL
VanEck Pharmaceutical ETF
PPH
$993M
| $4.39M | ﹤0.01% |
+66,100
| New | +$4.24M |
|
|
BLD
3578
DELISTED
TopBuild
BLD
| $4.39M | ﹤0.01% |
23,856
+11,882
| +99% | +$2.1M |
|
3579
CALL
Hercules Capital
HTGC
$3.27B
| $4.39M | ﹤0.01% |
304,500
+113,500
| +59% | +$1.44M |
|
3580
Trustmark
TRMK
$2.69B
| $4.39M | ﹤0.01% |
160,714
+118,505
| +281% | +$2.97M |
|
3581
PagSeguro Digital
PAGS
$2.45B
| $4.39M | ﹤0.01% |
77,129
-102,620
| -57% | -$4.61M |
|
|
OZON
3582
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $4.39M | ﹤0.01% |
+105,925
| New | +$4.62M |
|
3583
PUT
Rhythm Pharmaceuticals
RYTM
$7.38B
| $4.38M | ﹤0.01% |
147,400
+90,700
| +160% | +$2.31M |
|
|
FAZ
3584
PUT
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
| $4.38M | ﹤0.01% |
7,575
-6,228
| -45% | -$5.29M |
|
3585
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.35B
| $4.38M | ﹤0.01% |
45,336
-21,009
| -32% | -$1.89M |
|
3586
PUT
United Microelectronic
UMC
$49.6B
| $4.38M | ﹤0.01% |
519,500
+472,300
| +1,001% | +$3.08M |
|
3587
PUT
Waters Corp
WAT
$40.7B
| $4.38M | ﹤0.01% |
17,700
-52,300
| -75% | -$11.9M |
|
3588
Power Integrations
POWI
$2.88B
| $4.38M | ﹤0.01% |
53,471
+38,560
| +259% | +$2.62M |
|
|
KYNB
3589
CALL
Kyntra Bio
KYNB
$32.5M
| $4.37M | ﹤0.01% |
4,716
+952
| +25% | +$1M |
|
3590
Planet Fitness
PLNT
$4.03B
| $4.37M | ﹤0.01% |
56,276
+41,042
| +269% | +$2.87M |
|
|
SGMO
3591
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $4.36M | ﹤0.01% |
279,649
-51,699
| -16% | -$606K |
|
|
QVCGA
3592
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $4.36M | ﹤0.01% |
7,956
-68
| -0.8% | -$30.6K |
|
3593
PUT
Masco
MAS
$14.4B
| $4.36M | ﹤0.01% |
79,400
-30,100
| -27% | -$1.66M |
|
3594
PUT
Box
BOX
$4.8B
| $4.36M | ﹤0.01% |
241,500
-131,900
| -35% | -$2.3M |
|
3595
iShares Biotechnology ETF
IBB
$10.5B
| $4.36M | ﹤0.01% |
28,770
-151,686
| -84% | -$21.7M |
|
|
MAXN
3596
CALL
DELISTED
Maxeon Solar Technologies
MAXN
| $4.35M | ﹤0.01% |
1,534
+1,390
| +965% | +$3.07M |
|
3597
PUT
8x8 Inc
EGHT
$287M
| $4.35M | ﹤0.01% |
126,200
-279,300
| -69% | -$5.99M |
|
3598
PUT
McCormick & Company Non-Voting
MKC
$14.9B
| $4.35M | ﹤0.01% |
45,500
-396,300
| -90% | -$37.4M |
|
|
UFS
3599
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
| $4.35M | ﹤0.01% |
137,400
-103,500
| -43% | -$2.95M |
|
|
NEWR
3600
DELISTED
New Relic, Inc.
NEWR
| $4.35M | ﹤0.01% |
+66,489
| New | +$4.1M |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.